{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:37:15Z","timestamp":1790307435690,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004561","name":"Ministry of Education and Science of the Republic of Kazakhstan","doi-asserted-by":"publisher","award":["0115\u0420\u041a00389"],"award-info":[{"award-number":["0115\u0420\u041a00389"]}],"id":[{"id":"10.13039\/501100004561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["93664"],"award-info":[{"award-number":["93664"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2017.00151","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T04:35:56Z","timestamp":1494218156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1"],"prefix":"10.3389","volume":"7","author":[{"given":"Aleksandr I.","family":"Ilin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat E.","family":"Kulmanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya S.","family":"Korotetskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat A.","family":"Islamov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshara K.","family":"Akhmetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina V.","family":"Lankina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg N.","family":"Reva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"B","DOI":"10.2471\/blt.07.043802","article-title":"Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment","volume":"86","author":"Awofeso","year":"2008","journal-title":"Bull. World Health Organ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16741","DOI":"10.1074\/jbc.272.27.16741","article-title":"Gene knockout reveals a novel gene cluster for the synthesis of a class of cell wall lipids unique to pathogenic mycobacteria","volume":"272","author":"Azad","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2958.2002.02813.x","article-title":"Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?","volume":"44","author":"Banu","year":"2002","journal-title":"Mol. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","article-title":"Multidrug evolutionary strategy to reverse antibiotic resistance","volume":"351","author":"Baym","year":"2016","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19845","DOI":"10.1074\/jbc.M100662200","article-title":"Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier","volume":"276","author":"Camacho","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B6","volume-title":"Parameters for Compartment Free Pharmacokinetics: Standardisation of Study Design, Data Analysis and Reporting","author":"Cawello","year":"1999"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nm1110","article-title":"Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness","volume":"10","author":"Cohen","year":"2004","journal-title":"Nat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1473-3099(03)00483-3","article-title":"The effect of drug resistance on the fitness of Mycobacterium tuberculosis","volume":"3","author":"Cohen","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/clinids\/24.Supplement_1.S121","article-title":"Drug-resistant tuberculosis: review of the worldwide situation and the WHO\/IUATLD Global Surveillance Project","volume":"24","author":"Cohn","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1365-2958.1993.tb01253.x","article-title":"Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot","volume":"9","author":"Finken","year":"1993","journal-title":"Mol. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/mmi.12981","article-title":"Phylogeny to function: PE\/PPE protein evolution and impact on Mycobacterium tuberculosis pathogenicity","volume":"96","author":"Fishbein","year":"2015","journal-title":"Mol. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1126\/science.1124410","article-title":"The competitive cost of antibiotic resistance in Mycobacterium tuberculosis","volume":"312","author":"Gagneux","year":"2006","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0167989","DOI":"10.1371\/journal.pone.0167989","article-title":"Experimental evolution of Mycobacterium tuberculosis in human macrophages results in low-frequency mutations not associated with selective advantage","volume":"11","author":"Guerrini","year":"2016","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1415332","article-title":"Delamanid for extensively drug-resistant tuberculosis","volume":"373","author":"Gupta","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijmm.2006.10.002","article-title":"DNA adenine methylation and bacterial pathogenesis","volume":"297","author":"Heusipp","year":"2007","journal-title":"Int. J. Med. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2958.1995.tb02238.x","article-title":"Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis","volume":"15","author":"Heym","year":"1995","journal-title":"Mol. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1164\/rccm.201502-0372LE","article-title":"Delamanid and Bedaquiline resistance in Mycobacterium tuberculosis ancestral Beijing genotype causing extensively drug-resistant tuberculosis in a Tibetan Refugee","volume":"193","author":"Hoffmann","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B18","unstructured":"IlinA. I. KulmanovM. E. Antibacterial Agent for Treating Infectious Diseases of Bacterial Origin2014"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e01272","DOI":"10.1128\/genomeA.01272-15","article-title":"Complete genome sequence of the multidrug- resistant clinical isolate Mycobacterium tuberculosis 187.0, used to study an effect of drug susceptibility reversion by a new medicinal drug FS-1","volume":"3","author":"Ilin","year":"2015","journal-title":"Genome Announc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/2210289201708010033","article-title":"Constraints of drug resistance in Mycobacterium tuberculosis\u2013prospects for pharmacological reversion of susceptibility to antibiotics","volume":"8","author":"Ilin","year":"2017","journal-title":"Open Conf. Proc. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJM199309093291108","article-title":"Treatment of multidrug-resistant tuberculosis","volume":"329","author":"Iseman","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2754\/avb201685010009","article-title":"Acute and subchronic toxicity studies of the original drug FS-1","volume":"85","author":"Kalykova","year":"2016","journal-title":"Acta Vet. Brno"},{"key":"B23","first-page":"131","article-title":"Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing","volume":"119","author":"Kapur","year":"1999","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1128\/JCM.44.3.811-818.2006","article-title":"Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis","volume":"44","author":"Kr\u00fc\u00fcner","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"14711","DOI":"10.1073\/pnas.0902437106","article-title":"The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis","volume":"106","author":"Luciani","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2229-516X.112228","article-title":"Bedaquiline: first FDA-approved tuberculosis drug in 40 years","volume":"3","author":"Mahajan","year":"2013","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature02759","article-title":"The challenge of emerging and re-emerging infectious diseases","volume":"430","author":"Morens","year":"2004","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1093\/nar\/8.19.4321","article-title":"Rapid isolation of high molecular weight plant DNA","volume":"8","author":"Murray","year":"1980","journal-title":"Nucleic Acids Res."},{"key":"B29","volume-title":"Guide for the Care and Use of Laboratory Animals, 8th Edn","year":"2010"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3201\/eid1209.060361","article-title":"Multidrug-resistant Mycobacterium tuberculosis, Bangui, Central African Republic","volume":"12","author":"Nouvel","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1365-2958.2006.05585.x","article-title":"Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria","volume":"63","author":"Okamoto","year":"2007","journal-title":"Mol. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1473-3099(11)70316-4","article-title":"The crisis of no new antibiotics \u2013 what is the way forward?","volume":"12","author":"Piddock","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(13)62675-6","article-title":"Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study","volume":"383","author":"Pietersen","year":"2014","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1128\/IAI.70.9.4955-4960.2002","article-title":"Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans","volume":"70","author":"Pym","year":"2002","journal-title":"Infect. Immun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1128\/AAC.47.4.1241-1250.2003","article-title":"Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis","volume":"47","author":"Ramaswamy","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1128\/AAC.11.5.852","article-title":"Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus","volume":"11","author":"Reading","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1128\/AAC.01482-12","article-title":"Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis","volume":"57","author":"Rodrigues","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","volume-title":"Histology","author":"Ross","year":"2006"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1000002","DOI":"10.1371\/journal.pmed.1000002","article-title":"Tuberculosis drug resistance mutation database","volume":"6","author":"Sandgren","year":"2009","journal-title":"PLoS Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nm0696-662","article-title":"Mutations in pncA, a gene encoding pyrazinamidase\/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus","volume":"2","author":"Scorpio","year":"1996","journal-title":"Nat. Med."},{"key":"B41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JB.72.2.132-141.1956","article-title":"Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro","volume":"72","author":"Segal","year":"1956","journal-title":"J. Bacteriol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1086\/524891","article-title":"Infectious diseases society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1128\/AAC.41.8.1677","article-title":"Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations","volume":"41","author":"Sreevatsan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1086\/321834","article-title":"Development and spread of bacterial resistance to antimicrobial agents: an overview","volume":"33","author":"Tenover","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0155127","DOI":"10.1371\/journal.pone.0155127","article-title":"High persister mutants in Mycobacterium tuberculosis","volume":"11","author":"Torrey","year":"2016","journal-title":"PLoS ONE"},{"key":"B46","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/AAC.00749-08","article-title":"New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development","volume":"53","author":"van den Boogaard","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1128\/IAI.06370-11","article-title":"Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacterium marinum","volume":"80","author":"Yu","year":"2012","journal-title":"Infect. Immun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2334-8-10","article-title":"Mutidrug-resistant tuberculosis","volume":"8","author":"Zager","year":"2008","journal-title":"BMC Infect. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T02:45:52Z","timestamp":1602038752000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":48,"alternative-id":["10.3389\/fcimb.2017.00151"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2017.00151","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"article-number":"151"}}